| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afc5d8c9ee6673323cee3e2d19bc5146 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-525 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
1997-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a8ea549e5a04d2237d0e55465f9e296
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cbd317cf183816619576fceea8ca552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a38b04036dffcde6550326a66817bd9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_814924bede2c7dda1284f73eae273a85 |
| publicationDate |
2000-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20000038040-A |
| titleOfInvention |
Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods |
| abstract |
The present invention provides proteins that selectively inhibit the proliferation of androgen-independent prostate cancer cells. The present invention also provides nucleic acid molecules encoding the protein, including nucleic acid molecules suitable for use in gene therapy to treat individuals suffering from androgen-independent prostate cancer. The present invention further provides a substance composition which selectively kills androgen-independent prostate cancer cells and comprises the present protein and a toxic site bound thereto. Finally, the present invention provides related pharmaceutical compositions and methods for treating androgen-independent prostate cancer. |
| priorityDate |
1996-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |